ULK1 and neoplasm: Inspection of cancer genomics data from a combined study of 1034 pancreatic cancer samples in the Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) data sets using cBioPortal depicted that ULK1/2 is predominantly mutated or amplified in the tumour samples with high expression and mutation of YAP1 or PKM (Figure S5C).